Want to join the conversation?
In 4Q15, $STJ posted sales of $580MM in its largest segment Cardiac Rhythm Management, down 15% from 4Q14. Atrial Fibrillation product sales fell 2% to $276MM. Cardiovascular sales fell 6% to $327MM while Neuromodulation product sales rose 3% to $128MM.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)